Cleared Traditional

K230933 - REMI Remote EEG Monitoring System (FDA 510(k) Clearance)

Jun 2023
Decision
88d
Days
Class 2
Risk

K230933 is an FDA 510(k) clearance for the REMI Remote EEG Monitoring System. This device is classified as a Reduced- Montage Standard Electroencephalograph (Class II - Special Controls, product code OMC).

Submitted by Epitel, Inc. (Salt Lake City, US). The FDA issued a Cleared decision on June 30, 2023, 88 days after receiving the submission on April 3, 2023.

This device falls under the Neurology FDA review panel. Regulated under 21 CFR 882.1400. Acquire, Display, Store, And Archive Electroencephalographic Signals From The Brain Using A User-specified And/or Sponsor-specified Locations With A Reduced Array (i.e. Less Than < 16) Of Electrodes.

Submission Details

510(k) Number K230933 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 03, 2023
Decision Date June 30, 2023
Days to Decision 88 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF

Device Classification

Product Code OMC - Reduced- Montage Standard Electroencephalograph
Device Class Class II - Special Controls
CFR Regulation 21 CFR 882.1400
Definition Acquire, Display, Store, And Archive Electroencephalographic Signals From The Brain Using A User-specified And/or Sponsor-specified Locations With A Reduced Array (i.e. Less Than < 16) Of Electrodes